
159 - Innovations in Crystallization Techniques for Active Pharmaceutical Ingredients (S11E9)
About this episode
This episode delves into the innovative approaches and considerations in the crystallization of active pharmaceutical ingredients (APIs). The discussion covers topics such as continuous crystallization, which leads to steady states with tight controls, which allow for more steady manufacturing, particle size control for the proper medication intake by the patients, and the development of robust and scalable salt formation processes. There is a discussion as to what each facet of these controls offers, how the new procedures are better than old, as well as the analytical testing that goes into it.
The solid state, polymorph and solubility of all facets are discussed. The discussion of solubility also takes lead way into how salt optimization needs to be done, how all the testing and results play out in all forms. The best and hows are answered about a long standing and complex method. In the end, the deep dive goes back to the analytical testing to bring to head where the innovations of medicine are going.
Get every episode summarized
Each time From Concept to Medicine - A Comprehensive Drug Development Journey publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from From Concept to Medicine - A Comprehensive Drug Development Journey

21 Atorvastatin (S24E21)
From Concept to Medicine - A Comprehensive Drug Development Journey

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The AL...
From Concept to Medicine - A Comprehensive Drug Development Journey

20 Liraglutide (S24E20)
From Concept to Medicine - A Comprehensive Drug Development Journey

18 Pioglitazone (S24E18)
From Concept to Medicine - A Comprehensive Drug Development Journey